September 28, 2018
Over the past few years, the health policy landscape in Brussels has been characterised by the member states’ intense request for greater access to medicines. The primary focus has been on how prices could be reduced to increase access. However, drug shortages have equally remained on the radar. In June 2016, the Dutch Council Conclusions on strengthening checks and balances on the pharmaceutical industry have stirred political developments that have led to the ongoing intellectual...
September 3, 2018
2019 represents the “Year of Change” for the European Union (a new European Parliament, a new political leadership for the European Commission, and the formal departure of the UK as a member of the EU). With the European elections coming up in 2019, Senior Vice President and Director of Public Affairs, Teresa Calvano, notes what issues you should have on your radar in the healthcare sector. For Calvano, the rise of e-health, the digital transformation...
September 13, 2017
FleishmanHillard is delighted to announce that Mr Claudio Murri and Dr Lukas Pfister have joined the firm as senior advisers to our technology and healthcare practices. Given the accelerating EU agendas in both of these sectors, increasing clients demands and opportunities for growth, we are excited to build upon existing expertise with these high caliber professionals. These senior profiles will work alongside our existing team of senior advisors which include Chris Davies, formerly the coordinator...